GlaxoSmithKline Consumer Healthcare Limited

Equities

500676

INE264A01014

GlaxoSmithKline Consumer Healthcare Limited Appoints S Madhavan as an Additional and Independent Director

September 25, 2018 at 08:18 am

GlaxoSmithKline Consumer Healthcare Limited announced that the Board of Directors have appointed Mr. S Madhavan as an Additional and Independent Director, with effect from September 25, 2018 till the upcoming Annual General Meeting.

Latest news about GlaxoSmithKline Consumer Healthcare Limited

GlaxoSmithKline Consumer Healthcare : Launches Saline Nasal Wash Product	20-12-17	MT
Market Chatter: GSK Consumer Plans Local Manufacturing of Polident Brand in India	20-11-30	MT
GlaxoSmithKline Consumer Healthcare : GSK Consumer Healthcare Launches Denture Care Brand in India	20-11-25	MT
InveniAI Corporation Enters Strategic Artificial Intelligence and Machine Learning Focused Collaboration with GlaxoSmithKline Consumer Healthcare	20-07-29	CI
GlaxoSmithKline Consumer Healthcare Limited(BSE:500676) dropped from S&P Global BMI Index	20-04-16	CI
GlaxoSmithKline Consumer Healthcare Limited(NSEI:GSKCONS) dropped from FTSE All-World Index	20-04-16	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q3 2020 Earnings Call, Feb 07, 2020	20-02-07
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-06	CI
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-08	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q2 2020 Earnings Call, Nov 08, 2019	19-11-08
GlaxoSmithKline Consumer Healthcare Limited Announces Resignation of Vivek Anand from the Board	19-09-27	CI
GlaxoSmithKline Consumer Healthcare Limited Announces Cessation of Directors	19-08-09	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q1 2020 Earnings Call, Aug 05, 2019	19-08-05
GlaxoSmithKline Consumer Healthcare Limited Declares Dividend for the Year Ended March 31, 2019	19-08-03	CI
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	19-08-01	CI
Glaxosmithkline Consumer Healthcare Limited Recommends Total Dividend for the Year Ended March 31, 2019, Payable on September 2, 2019	19-06-27	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q4 2019 Earnings Call, May 13, 2019	19-05-13
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	19-05-10	CI
GlaxoSmithKline Consumer Healthcare Limited Recommends Dividend, Payable on or Before September 1, 2019	19-05-10	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q3 2019 Earnings Call, Feb 15, 2019	19-02-15
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	19-02-14	CI
GSK Says Considering Potential Deal Including Merger Of Its Consumer Healthcare Unit	18-11-29	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q2 2019 Earnings Call, Nov 02, 2018	18-11-02
Glaxosmithkline Consumer Healthcare Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-10-31	CI
Unilever, Nestle And Coca-Cola Reportedly Begin Due Diligence On Glaxosmithkline Consumer Healthcare	18-10-26	CI

Chart GlaxoSmithKline Consumer Healthcare Limited

Duration

Period

Chart GlaxoSmithKline Consumer Healthcare Limited

More charts

Company Profile

GlaxoSmithKline Consumer Healthcare Limited is an India-based healthcare company. The Company offers products such as consumer healthcare, digestive health, pain management, respiratory, oral care, and pharmaceuticals. The Company's over the counter (OTC) products include Crocin, a household medicine for relieving pain and body ache; Eno, an antacid for instant relief from acidity, gastric discomfort and heart burn; Iodex, a pain reliever available under various types, including Iodex Double Power, Iodex Headfast and Iodex Ultra Gel; Ostocalcium, a chewable calcium tablets; Otrivin, a nasal decongestant, and Sensodyne, which is a sensitivity toothpaste brand. The Company has manufacturing facilities at Nabha, Punjab; Rajahmundry, Andhra Pradesh, and Sonepat, Haryana. The Company markets its products in India, Sri Lanka, Bangladesh, Nepal, the Middle East, Myanmar, Kenya and Pakistan.

Sector

More about the company